Status:
COMPLETED
Once Daily vs Twice Daily Administration of Gonadotropins in Assisted Reproductive Technologies (ART)
Lead Sponsor:
Virginia Center for Reproductive Medicine
Conditions:
Pregnancy
Eligibility:
FEMALE
21-39 years
Brief Summary
This is a prospective randomized study evaluating dosing frequency of gonadotropin administration in ART cycles.
Detailed Description
Using once daily or bid dosing of gonadotropins in ART has been arbitrary with no studies showing whether splitting the medication dose improves ART parameters. This study was undertaken to provide an...
Eligibility Criteria
Inclusion
- women \< 40 undergoing ART
Exclusion
- women \> 40
- endometriomas
- severe cervical stenosis
- testicular sperm
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2010
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00740025
Start Date
January 1 2006
End Date
January 1 2010
Last Update
October 14 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virginia Center for Reproductive Medicine
Reston, Virginia, United States, 20190